{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Cilengitide",
  "nciThesaurus": {
    "casRegistry": "188968-51-6",
    "chebiId": "",
    "chemicalFormula": "C27H40N8O7",
    "definition": "A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity.  Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.",
    "fdaUniiCode": "4EDF46E4GI",
    "identifier": "C1834",
    "preferredName": "Cilengitide",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [],
    "synonyms": [
      "CILENGITIDE",
      "Cilengitide",
      "EMD 121974",
      "EMD-121974",
      "cilengitide",
      "cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl)"
    ]
  }
}